MENU
CLSDQ
AS OF
Feb 3 closing price
Price
$0.67
Change
-$3.69 (-84.63%)
Capitalization
3.51M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CLSDQ
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Clearside Biomedical (CLSDQ) Ownership - Who owns Clearside Biomedical?

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.51M
P/E Ratio
N/A
Total Cash
6.8M
Projected Growth
N/A
Total Debt
446K
Revenue
3.33M
Risk (Beta)
2.15
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
0.65 USD as % of share price

Fundamentals

CLSDQ
Capitalization
3.51M
P/E Ratio
N/A
Risk (Beta)
2.15
Dividend Yield
N/A
Total Cash
6.8M
Total Cash/Share
1.30
Total Debt
446K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.65%
Revenue
3.33M
ROE
N/A
Book Value
-53.95M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-5.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
78K
Current Ratio
2.98
Current Revenue Per Employee
6281.25
Dividends Per Share - Security
N/A
EBITDA
-14.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-127.43
Shares Held By Institutions
3.44M
Shares Outstanding - Current
5.23M
Total Liabilities
65.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-4.965
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CLSDQ
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for CLSDQ
A.I. Advisor
published General Information

General Information

a developer of drug therapies to treat chronic, blinding diseases of the eye

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A